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Abstract  
Biofilm producer bacteria cause nosocomial, chronic, and recurrent human infections. It is hard to treat 
biofilm-embedded bacteria because they are more resistant to antimicrobials than planktonic bacteria. 
The present study aimed to investigate different methods for detecting biofilms in the clinical isolates 
of Escherichia coli and Pseudomonas aeruginosa. The study was carried out at the Department of 
Microbiology, Ardabil Branch, Islamic Azad University, Ardabil, Iran, from January 2019 to June 2019. 
A total of 320 clinical samples were collected from educational and medical centers in Tehran, Iran 
which from them 100 isolates of E. coli and P. aeruginosa were identified by standard microbiological 
procedures and subjected to biofilm detection methods. Biofilm detection was tested by Congo red agar 
(CRA), tube method (TM), microtiter plate assay (MTPA). The MTPA was considered to be superior to 
CRA and tube TM. From the total of 100 clinical isolates, MTPA detected 38 (38%) isolates as biofilm-
positive phenotype, of which 30 as strong, and 8 as moderate biofilm-forming isolates. It can be 
concluded from the current study that the MTPA is a more quantitative and dependable assay for the 
detection of biofilm-forming microorganisms as compared to other methods, and it can be 
recommended as a general screening method for the detection of biofilm-producing bacteria in 
laboratories.  
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1. Introduction  
Microorganisms can live in one of two 
phenotypes: sessile or plankton. Planktonic are free-
floating microorganisms. The sessile phenotype 
results from the binding of microorganisms to solid 
surfaces, their irreversible binding, and the 
development of exopolysaccharides with a gradual 
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increase in cell secretions' thickness [1]. A biofilm is a 
collection of microbial cells that are irreversibly 
enclosed in a polysaccharide matrix and bonded 
together on biotic surfaces such as host cells or abiotic 
surfaces such as medical devices [2]. Microbial cells 
that grow in a biofilm are physiologically different 
from planktonic cells of the same organism, which, in 
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contrast, are single-cell and may float or swim in a 
liquid environment [3].  
Biofilms are considered a serious public health 
problem due to the increased resistance of the 
constituent organisms to antimicrobial drugs and the 
ability to cause infection in patients who have been 
implanted with medical devices [4, 5].The biofilm 
matrix blocks the penetration of antibiotics and 
prevents them from reaching the cells inside the 
biofilm [6]. Studies have shown that bacterial biofilms 
cause 80% of microbial infections that are very difficult 
to eradicate and treat with antibiotics [7]. One of the 
most important pathogens that produce strong 
biofilms is Escherichia coli. Previous studies on the 
survival of biofilm-related pathogens also indicate that 
biofilms may play an essential role in the persistence 
and release of stress-sensitive organisms into the 
environment. The results show that E. coli resists food 
deficiency conditions, and the interaction of this 
bacterium with Pseudomonas aeruginosa can 
increase E. coli growth in biofilm [8].  
Biofilm formation contributes to the pathogenesis 
of P. aeruginosa in acute as well as chronic infections 
in clinical cases [9]. P. aeruginosa is currently 
considered the leading cause of ventilator-associated 
pneumonia (VAP) in the ICU. Infections caused by this 
bacterium occur mainly in patients with critical 
condition and immunodeficiency and increase the 
morbidity and mortality in these patients as well as 
increase the incidence of resistance of P. aeruginosa to 
antibiotics [10]. 
To control chronic and recurrent infections, it is 
essential to identify microorganisms' biofilms, 
maturity, and dispersion [11]. There are various 
laboratory methods to evaluate the production of 
biofilm in bacteria. Biofilm growth and observation 
with microscopes such as confocal scanning laser 
microscope (CLSM), quantitative method of closed 
systems under static conditions such as tissue culture 
plate (TCP) method and observation with non-specific 
color, floating biofilms (Air liquid interface (ALI)), 
bioluminescent assay, observation of bacteria colonies 
on the surface of a solid medium such as Congo red 
agar (CRA) and the simple tube method (TM) are 
among the biofilm measurement methods [12]. 
Microtiter plate assay (MTPA) is a screening method 
for comparing adhesion patterns. It is the most widely 
used quantitative method for detecting biofilm 
production. In the CRA method, a positive result is 
shown by the black colony and the dry crystal 
consistency. A pink colony appears in the absence of 
biofilm [13]. 
Laboratory study of biofilm production by 
bacteria can be affected by the choice of a specific 
culture medium. The conditions that the bacterium 
encounters during growth can encourage or suppress 
biofilms production or cause biofilms with unusual 
structures [14]. This study aimed to investigate the 
methods (microtiter plate methods, tube method, and 
Congo red agar) for the detection of biofilm formation 
in the clinical isolates of E. coli and P. aeruginosa. The 
sensitivity and specificity of the methods have been 
determined through statistical analysis. The MTPA 
method was considered the gold standard for this 
study and compared with data from TM and CRA 
assays. True positives were biofilm producers by 
MTPA, TM, and CRA assays. False-positive were 
biofilm producers by TM and CRA assay and not by 
MTPA method. False-negative were the isolates that 
were non-biofilm producers by TM and CRA but were 
producing biofilm by MTPA method. True negatives 
are those which were non-biofilm producers by all the 
methods. 
  
2. Materials and Methods  
2.1 Sample collection 
Out of 320 clinical samples collected from 
educational and medical centers in Tehran, Iran from 
January 2019 to June 2019, 50 isolates of E. coli and 
50 isolates of P. aeruginosa were identified and 
subjected to biofilm formation detection. These 
isolates were identified by, colonial morphological 
analysis on Eosin Methylene Blue (EMB) Agar (for E. 
coli isolates) and Cetrimide Agar (for P. aeruginosa 
isolates) and standard microbiological procedures 
such as Gram staining, catalase test, cytochrome 
oxidase reaction, motility, and biochemical tests. 
These isolates were selected for biofilm formation 
evaluation. Reference strain of positive biofilm 
producer P. aeruginosa ATCC 9027, E. coli ATCC 
25922 were used as controls. 
 
2.2 Microtiter plate assay (MTPA) 
Each of the collected and reference strains was 
cultured on Tryptic Soy Agar (TSA) (Merck, Germany) 
medium and incubated overnight at 37°C. Fresh 
colonies were cultured in 10 ml Tryptic Soy Broth 
(TSB) (Merck, Germany) medium in a sterile tube and 
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incubated for 15-18 h at 37°C with a shake at 200 rpm. 
The optical absorption of each liquid culture was 
adjusted using a fresh medium with an OD of 0.1 at 
620 nm. Bacterial cultures were diluted, and a 
suspension equivalent to half McFarland was 
prepared in TSB medium. 200 μl of the suspension 
prepared from each bacterial strain was transferred 
into 96 polystyrene plate wells. The plates were 
incubated at 37 °C for 96 h. The control organism was 
also incubated, diluted, and added to the culture plate. 
Negative control wells contained inoculated sterile 
broth. After this time, each well's contents were 
removed and washed twice with phosphate buffer 
solution (PBS) (pH 7). This removed free-floating 
bacteria. After drying, the wells were fixed with 95% 
Methanol for 10 minutes and then stained with Crystal 
violet (1%) for five minutes. The plates were emptied, 
and an excess stain was washed by sterile distilled 
water. The wells were filled with 100 μl of Glacial acetic 
acid solution (33%) and biofilm formation has been 
evaluated at 570 nm with an ELISA auto reader 
(Biotek ELx800, USA) [9]. 
 
2.3 Congo red agar (CRA) 
The Congo red indicator (8 g/L) was prepared 
separately from the other medium constituents as a 
concentrated aqueous solution and autoclaved (121°C 
for 10 minutes). Then it was added to the autoclaved 
Muller Hinton agar medium (Merck, Germany) (10 
g/ml) with sucrose (50 g/L) at 55°C. Test organisms 
were cultured on the CRA medium and incubated 
aerobically for 24 - 48 h at 37 °C. Black colonies with a 
dry crystalline consistency indicated biofilm 
production [1]. 
 
2.4 Tube method (TM) 
A loopful of the bacterial suspension was 
transferred to a tube containing 10 ml of LB broth 
(Merck, Germany) medium with glucose (2%). The 
tubes were incubated for 24 h at 37°C. The contents of 
the tubes were then removed and washed with PBS 
(pH 7.3). Then the dried tubes were stained with 
Crystal violet (1%). Excess dye was washed with sterile 
distilled water. Tubes were dried in the inverted 
position. Isolates forming slime or biofilm-based on 
Crystal violet color's thickness on the tube's bottom 
and the wall was observed and recorded. The 
observation of a visible thin layer on the wall and 
bottom of the tube was considered a moderate biofilm. 
The observation of a thick layer visible on the wall and 
bottom of the tube was considered a strong biofilm. 
The lack of a visible layer on the wall and bottom of the 
tube was considered non-biofilm formation and 
negative. The experiment was performed in three 
replications [3]. 
 
2.5 Statustical analysis 
The results were entered into Microsoft Excel 
2016 and were analyzed by using SPSS version 25 
(SPSS Inc., Chicago, IL, USA). Spearman's correlation 
test was used to define the direction of association. P-
value <0.05 was considered statistically significant. 
 
3. Results 
Of the 100 E. coli and P. aeruginosa isolates, 38 
(38%) isolates showed a biofilm-positive phenotype 
under the optimized conditions in MTPA (Figure 1) 
and isolates were further classified as strong, 
moderate, weak, and no biofilm (Table 1). CRA assay 
led to different results, only 26.3% of isolates showed 
black colonies with dry crystalline morphology after 
24-48 hours (Table 2). Though the CRA assay can well 
detect biofilm-producing strains, weak producers 
were difficult to discriminate from biofilm negative 
isolates. No direct correlation between colony 
morphology on CRA and MTPA results was observed. 
In TM, strong biofilm producers could be easily 
detected, whereas it was difficult to differentiate 
between moderate and weak biofilm-forming isolates 
which affected its performance in terms of sensitivity 
and specificity. Statistical analysis of TM and CRA 
methods for detection of biofilm formation in isolates 
using MTPA as a gold standard (n=100) showed that 
TM assay has more sensitivity and specificity than the 
CRA method (Table 3). Biofilm formation in the 
isolates by either of the methods was 16% and 60% for 
E. coli and P. aeruginosa, respectively. 
 
Discussion 
Biofilm-producing bacteria cause many chronic 
and recurrent infections that are difficult to treat. 
Treatment and control of biofilm-associated infections 
is an essential issue in hospitals and medical care. 
These bacteria exhibit resistance by different assays 
such as restricted penetration of antibiotics into 
biofilms and expression of resistance genes by 
facilitating the exchange of plasmids responsible for 
drug resistance due to proximity of cells within 
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biofilms. There are a lot of different assays for 
detecting biofilm [15, 16].  
In this study, we evaluated 100 isolates by three 
screening methods for their ability in biofilm 
formation. In the MTPA, the number of isolates 
showing biofilm formation was 38 (38%) (30 strong 
and 8 moderate) and no weak biofilm producers were 
detected. A previous study showed from the 50 clinical 
 
 































control+ S54 S66 S57 S62 S40 S59 S43
S35 S53 S63 S45 S46 S52 S19 S61
S15 S14 S48 S49 S4 S21 S18 S8
S64 S22 S47 S34 S16 S26 control -
Table 1. Interpretation of biofilm formation by average OD value in microtiter plate assay 
 
Biofilm formation OD isolate (at 570 nm) ODc Isolates 
Strong OD isolate>0.929 OD isolate>4×ODc 
E41, E42, E43, E45, E48, E58, 
E60, S66, S57, S62, S40, S59, 
S35, S53, S63, S46, S34, S16, 
S52, S19, S61, S15, S48, S4, 
S21, S18, S8, S26, positive 
controls 
Moderate 0.464<OD isolate≤0.929 2×ODc <OD isolate≤4×ODc 
S54, S43, S45, S47, S14, S49, 
S64, S22 
Weak 0.232<OD isolate≤0.464 ODc <OD isolate≤2×ODc - 
No biofilm detected OD isolate≤0.232 OD isolate≤ ODc - 
 
Optical density cut-off value (ODc) = average OD of negative control + 4x standard deviation (SD) of negative control = 0.232 
Standard deviation (SD) = 0.03214 
E: E. coli; S: P. aeruginosa 
 









Strong 30 (78.95) 13 (34.21) 10 (26.32) 
Moderate 8 (21.05) 13 (34.21) 14 (36.84) 
Weak/none 0 12 (31.58)  14 (36.84) 
 
MTPA: microtiter plate assay, TM: Tube method, CRA: Congo red agar 
 
Table 3. Statistical analysis of TM and CRA methods for 
detection of biofilm formation in isolates using MTPA as a 
standard (n=100) 
 
Detection methods Sensitivity Specificity 
TM 70% 83% 
CRA 50% 71% 
 
MTPA: microtiter plate assay, TM: Tube method, CRA: Congo red 
agar 
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isolates, 32 were biofilm producers (3 strong and 29 
moderate) and 18 were weak/non-biofilm [17]. In 
another study, of the 50 isolates, 25 each were 
environmental and clinical. The number of biofilm 
producers reported in CRA and MTPA was 7 (14%) 
and 30 (60%), respectively which is consistent with the 
results of the current study [12]. In the current study 
with the CRA assay, 29 (76.32%) were found to be 
biofilm-producing bacteria and 9 (23.68%) as non-
biofilm producers. The CRA method showed little 
correlation with the other methods. Siddhiqui et al. 
reported that the CRA method is not appropriate for 
biofilm detection. Out of 112 clinical isolates, CRA 
detected only 14.25% as biofilm producers as 
compared to TM which detected 29.46% as biofilm-
forming bacteria [1]. The tube method also detected 
38% isolates as biofilm producers. This method 
correlated with MTPA for identifying biofilm 
producers, but it was difficult to differentiate between 
high, moderate, and weak producers due to the 
variability in the results detected by different 
observations. Several studies recommend the analysis 
of biofilm formation via TM by different observers [18, 
19]. TM and CRA are considered to be less sensitive 
than the MTPA, as some clinical isolates that were 
non-adherent, weak, or moderate biofilm producers in 
the TM and CRA assays showed strong biofilm 
patterns in the MTPA. So MTPA was selected as a gold 
standard for statistical analysis. In the current study 
sensitivity and specificity of TM were 70% and 83%, 
respectively. For the CRA assay, sensitivity and 
specificity were lower at 50% and 71%, respectively. So 
following the previous studies, TM and CRA cannot be 
recommended as general screening tests to identify 
biofilm-producing isolates since they can yield false 
positive or false negative results [12, 16, 20]. No 
significant relationship can be reported from the 
correlation of biofilm formation with organisms 
isolated because other factors such as the isolation 
source or the type of infection, antibiotic resistance, 
and genetic, physiological, and biochemical 
differences of the isolates should be considered to 
investigate the relationship between the genus of the 
isolates and the techniques used to identify biofilm 
formation. Conclusively, MTPA is a more reliable 
quantitative assay for detecting biofilm formation 
among clinical isolates. The tube method may also be 
considered in a fast screening of biofilm producers. 
Hence, measures for the early detection of biofilm 
producers in hospital environments and patients 
should be considered. This will decrease the rate of 
mortality of infections that are seemingly untreatable 
due to the presence of biofilms. Limitations 
encountered in this study were sampling, analytical 
and equipment limitation to investigate other 
screening and confirmatory assays of biofilm 
formation and not considering the effect of gene factor 
in biofilm formation. 
Prevention and control against potential biofilm 
forming clinical pathogenic isolates is an essential step 
towards the management of chronic and recurrent 
infections. There are different biofilm detection 
methods like MTPA, TM, and CRA. A suitable method 
that is cost-effective easy to do and requires less 
technical expertise is the need of the hour. Results of 
the current study showed that MTPA is a suitable and 
reliable assay that is more efficient than the other 
detecting biofilm formation methods. Considering the 
ease of doing the test, rapidity, and cost-effectiveness, 
the CRA method and TM can be considered for biofilm 
detection but not as general and reliable detection 
methods. 
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